HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

4-vinyl-1-cyclohexene dioxide

activates caspase cascades; structure
Also Known As:
1-epoxyethyl-3,4-epoxycyclohexane; 4-vinylcyclohexene diepoxide; vinyl cyclohexane diepoxide; vinyl cyclohexene diepoxide; vinylcyclohexene diepoxide; 3-oxiranyl- 7-oxabicyclo(4.1.0)heptane
Networked: 28 relevant articles (0 outcomes, 3 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Hoyer, Patricia B: 6 articles (03/2013 - 07/2006)
2. Marion, Samuel L: 5 articles (03/2013 - 07/2006)
3. Barton, Jennifer K: 4 articles (03/2013 - 07/2006)
4. Brooks, Heddwen L: 2 articles (01/2020 - 09/2009)
5. Ahn, Changhwan: 2 articles (01/2018 - 01/2017)
6. Jeung, Eui-Bae: 2 articles (01/2018 - 01/2017)
7. Kang, Hee Young: 2 articles (01/2018 - 01/2017)
8. Tran, Dinh Nam: 2 articles (01/2018 - 01/2017)
9. Brewer, Molly A: 2 articles (03/2013 - 07/2012)
10. Rice, Photini F: 2 articles (03/2013 - 07/2012)

Related Diseases

1. Ovarian Neoplasms (Ovarian Cancer)
2. Infertility (Sterility)
3. Cardiomegaly (Heart Hypertrophy)
4. Primary Ovarian Insufficiency
5. Neoplasms (Cancer)
07/01/2006 - "Rats are exposed to repeated daily dosing (20 days) with 4-vinylcyclohexene diepoxide (VCD) to cause early ovarian failure (model for postmenopause), and ovaries are directly exposed to 7,12-dimethylbenz(a)anthracene (DMBA) to cause abnormal ovarian proliferation and neoplasia. "
05/01/1989 - "The results of this modified test are compared to those of the linear trend test in proportions, the incidental tumor test, the logistic regression score test, the life table test, and the truncated trend test using information on the incidence of combined alveolar/bronchiolar adenomas or carcinomas in female B6C3F1 mice exposed to vinylcyclohexene diepoxide."
08/01/2012 - "There are three presumable mechanisms involved in the development of POI, namely apoptosis acceleration, follicular maturation blocking and premature follicle activation, through the following studied causes: (i) chromosomal abnormalities or gene mutations: mostly involve X chromosome, such as FMR1 premutation; more and more potentially causal genes have been screened recently; (ii) metabolic disorders such as classic galactosaemia and 17-OH deficiency; (iii) autoimmune mediated ovarian damage: observed alone or with some certain autoimmune disorders and syndromes; but the specificity and sensitivity of antibodies towards ovary are still questionable; (iv) iatrogenic: radiotherapy or chemotherapy used in cancer treatment, as well as pelvic surgery with potential threat to ovaries' blood supply can directly damage ovarian function; (v) virus infection such as HIV and mumps; (vi) toxins and other environmental/lifestyle factors: cigarette smoking, toxins (e.g., 4-vinylcyclohexene diepoxide), and other environmental factors are associated with the development of POI. "

Related Drugs and Biologics

1. bcl-2-Associated X Protein (bcl 2 Associated X Protein)
2. anthracene
3. Proteins (Proteins, Gene)
4. Estrogens (Estrogen)
5. Antral
6. MicroRNAs (MicroRNA)
7. Amyloid beta-Peptides
8. 9,10-Dimethyl-1,2-benzanthracene
9. Protein Kinase C
10. Hormones (Hormone)

Related Therapies and Procedures

1. Therapeutics
2. Radiotherapy
3. Ovariectomy (Oophorectomy)
4. Drug Therapy (Chemotherapy)